编辑推荐——症状性颈动脉狭窄颈动脉干预时机:系统综述与Meta分析
该系统综述与Meta分析纳入71项研究、232 952例症状性患者,分析颈动脉内膜剥脱术(CEA)与颈动脉支架置入术(CAS)在症状发作后不同时间窗内的30天结局。结果显示症状发作≤2天时CAS的30天卒中(OR 0.70;95%CI 0.58-0.85)和死亡率(OR 0.41;95%CI 0.31-0.53)均高于CEA;加速CEA(vs 3-14天)30天卒中率1.4%(95%CI 0.9-1.8)vs 1.8%(95%CI 1.8-2.0),无统计学显著差异;加速CAS(vs 3-14天)卒中率无差异但死亡率显著更高(OR 2.76;95%CI 1.39-5.50)。结论认为症状发作2/7天内CEA比经股动脉CAS更安全,加速CEA符合国际指南可接受阈值,CAS理想时机尚未确定。
要点
- 症状发作≤2天时CAS的30天卒中(OR 0.70;95%CI 0.58-0.85)和死亡率(OR 0.41;95%CI 0.31-0.53)高于CEA。
- 加速CEA(vs 3-14天)30天卒中率1.4%(95%CI 0.9-1.8)vs 1.8%(95%CI 1.8-2.0),无统计学显著差异。
- 加速CAS(vs 3-14天)卒中率无差异,但死亡率显著更高(OR 2.76;95%CI 1.39-5.50)。
核心结论
- 目前,症状发作2/7天内CEA比经股动脉CAS更安全。
- 就绝对发生率而言,加速CEA符合国际指南可接受的阈值。
- CAS(当有指征替代CEA时)的理想时机尚未确定。
- 更多细粒度数据和干预时机的标准化报告将有助于未来监测。
研究设计与样本
- 系统综述与Meta分析,按照系统综述与Meta分析首选报告条目声明进行,在线检索Medline和Cochrane数据库,并对纳入研究进行方法学质量评估。
- 共纳入71项研究、232 952例症状性患者;包括34项前瞻性数据库的回顾性分析、9项前瞻性研究、3项随机对照试验、3项病例对照研究和22项回顾性研究。
- 终点为按症状发作至干预延迟和手术技术(CEA/CAS)分层的操作相关卒中和/或死亡。
主要发现
- 与CEA相比,症状发作≤2天时CAS的30天卒中率更高(OR 0.70;95%CI 0.58-0.85),死亡率更高(OR 0.41;95%CI 0.31-0.53)。
- 加速CEA(vs 3-14天)的30天卒中率为1.4%(95%CI 0.9-1.8)vs 1.8%(95%CI 1.8-2.0),无统计学显著差异。
- 加速CAS(vs 3-14天)卒中率无差异,但死亡率显著更高(OR 2.76;95%CI 1.39-5.50)。
关键数值与推荐
- CEA/CAS患者按不同时间窗分析:≤2天 vs 3-14天,以及≤7天 vs 8-14天。
- 症状发作≤2天时CAS vs CEA:30天卒中OR 0.70(95%CI 0.58-0.85),死亡率OR 0.41(95%CI 0.31-0.53)。
- 加速CEA(vs 3-14天):30天卒中率1.4%(95%CI 0.9-1.8)vs 1.8%(95%CI 1.8-2.0),无统计学显著差异。
- 加速CAS(vs 3-14天):卒中率无差异,死亡率OR 2.76(95%CI 1.39-5.50)。
临床怎么用
- 原文结论指出症状发作2/7天内CEA比经股动脉CAS更安全。
- 原文结论指出加速CEA的绝对发生率符合国际指南可接受的阈值。
- 原文指出CAS的理想时机尚未确定,需更多细粒度数据和标准化报告以利于未来监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This review aimed to analyse the timing of carotid endarterectomy (CEA) and carotid artery stenting (CAS) after the index event as well as 30 day outcomes at varying time periods within 14 days of symptom onset. METHODS: A systematic review was performed according to the Preferred Reporting Items for Systematic reviews and Meta-analysis statement, comprising an online search of the Medline and Cochrane databases. Methodical quality assessment of the included studies was performed. Endpoints included procedural stroke and/or death stratified by delay from the index event and surgical technique (CEA/CAS). RESULTS: Seventy-one studies with 232 952 symptomatic patients were included. Overall, 34 retrospective analyses of prospective databases, nine prospective, three RCT, three case control, and 22 retrospective studies were included. Compared with CEA, CAS was associated with higher 30 day stroke (OR 0.70; 95% CI 0.58 - 0.85) and mortality rates (OR 0.41; 95% CI 0.31 - 0.53) when performed ≤ 2 days of symptom onset. Patients undergoing CEA/CAS were analysed in different time frames (≤ 2 vs. 3 - 14 and ≤ 7 vs. 8 - 14 days). Expedited CEA (vs. 3 - 14 days) presented a sampled 30 day stroke rate of 1.4%; 95% CI 0.9 - 1.8 vs. 1.8%; 95% CI 1.8 - 2.0, with no statistically significant difference. Expedited CAS (vs. 3 - 14 days) was associated with no difference in stroke rate but statistically significantly higher mortality rate (OR 2.76; 95% CI 1.39 - 5.50). CONCLUSION: At present, CEA is safer than transfemoral CAS within 2/7 days of symptom onset. Also, considering absolute rates, expedited CEA complies with the accepted thresholds in international guidelines. The ideal timing for performing CAS (when indicated against CEA) is not yet defined. Additional granular data and standard reporting of timing of intervention will facilitate future monitoring.
引用
- Coelho A, Peixoto J, Mansilha A, et al. Editor's Choice - Timing of Carotid Intervention in Symptomatic Carotid Artery Stenosis: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2021. PMID: 34953681. doi:10.1016/j.ejvs.2021.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。